Diagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights)


USD 4,950.00

* Required Fields

USD 4,950.00


Be the first to review this product

This research service analyses the latest diagnostic and therapeutic developments that have occurred in the Alzheimer's disease sector, both from a technology and industry perspective.

Table of Contents

Diagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights), Executive SummaryResearch Scope and MethodologyResearch ScopeResearch MethodologyResearch HighlightsIndustry Overview and Key TrendsSnapshot of Noteworthy DevelopmentsDiagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights), Technology PrimerAlzheimer's Disease (AD) OverviewAD--A Century Old PathologyTheories in AD--The Role of Plaques and TanglesDisease Stages; Symptoms; and StatisticsAlzheimer's Disease Diagnosis and Therapy OverviewDiagnosis of ADTherapy OverviewDiagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights), Technology Intelligence in the AD SpaceNovel Mechanism of Action Drugs--Corporate AdvancementsA ‘Food Drug’ a Day May Keep Alzheimer’s Disease AwayProtecting Neurons by Targeting Cells’ PowerhousesNovel Neuroprotective Therapeutic Agents May Soon Validate 'Tau Theory' in Alzheimer'sSteroids Mediated Clearance of Amyloid Plaques in Alzheimer’sImproving Memory by Amplifying a Novel Receptor Implicated in NeurotransmissionA Broad Portfolio of Novel Drugs in the Pipeline for Alzheimer'sAD Therapeutics--Academic Research HighlightsStudy Identifies Molecule Involved in Beta-Amyloid Induced Neuron DeathVaccine for Alzheimer’s Triggers a Safe Immune Response and Clears Amyloid Plaques in a Mice StudyAdvances in AD Diagnosis--Corporate and Academic EffortsAlzheimer’s Diagnosis Made Simple and Safe with a Novel Blood TestAdvances in In Vitro Detection of the Amyloid Plaques in Alzheimer’sComputers to the Rescue–A Novel Approach to Early AD DiagnosisImaging Studies Reveal a Functional Maker Implicated in Early Alzheimer's DiseaseDiagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights), Technology Adoption Factor AnalysisForce-Field AnalysisThe Driving ForcesThe Restraining Forces and ChallengesStrategic Evaluation of the Competitive EnvironmentA Strategic Evaluation of AD Medication Space--SWOT AnalysisStrategic Assessment of Competitive Landscape and Attractiveness of AD Therapeutics Sector--WorldCurrent and FutureTrends; Industry Roadmap; and Strategic Recommendations (Analyst's Perspectives)Roadmap of Diagnostic and Therapeutic Trends in AD SectorStrategic Recommendations for Existing Symptomatic DrugsStrategic Recommendations for Disease Modifying DrugsDiagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights), Intellectual Property (IP) Scenario; Key ContactsThe IP ScenarioAlzheimer's Disease Therapeutics--Key PatentsAlzheimer's Disease Diagnostics--Key PatentsKey ContactsKey Corporate ContactsKey Academic ContactsDiagnostic and Therapeutic Trends in Alzheimer's Disease (Technical Insights), Decision Support Database TablesDatabase TablesTotal Healthcare Expenditure--World (2002 to 2012)Pharmaceutical R&D Expenditure--World (2002 to 2012)Number of Physicians--World (2002 to 2012)Number of Hospitals--World (2002 to 2012)Number of Nurses--World (2002 to 2012)

Related Research

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.